HG/LBCL-11q have a distinct molecular profile different from MYC-positive BL having a more complex genetic aberration background than BL (gains in chromosome 5q, 12p, and 18q as well as deletions in 6q) [56, 68–70]. The gene discussed is MYC; the disease is Burkitt lymphoma.